Aprea Therapeutics (APRE) Stock Chart & Stock Price History $1.85 +0.04 (+2.20%) Closing price 03:58 PM EasternExtended Trading$1.82 -0.03 (-1.62%) As of 05:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Aprea Therapeutics Stock Price Performance 5 Day Performance+17.45%1 Month Performance-1.07%3 Month Performance-52.69%6 Month Performance-52.81%Year-To-Date Performance-43.77%1 Year Performance-66.06% Receive APRE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aprea Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address APRE Stock Chart for Friday, May, 2, 2025 APRE Chart by TradingView Aprea Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/02/2025$1.81$1.85+2.20%$1.99$1.7934,905 shs$10.22 million05/01/2025$1.74$1.81+4.02%$1.91$1.7429,331 shs$10 million04/30/2025$1.70$1.74+2.35%$1.79$1.6214,177 shs$9.61 million04/29/2025$1.75$1.70-2.86%$1.79$1.6113,733 shs$9.34 million04/28/2025$1.58$1.75+11.11%$1.81$1.5583,736 shs$9.61 million04/25/2025$1.62$1.58-2.92%$1.69$1.5811,244 shs$8.65 million04/24/2025$1.50$1.62+8.16%$1.65$1.5122,934 shs$8.91 million04/23/2025$1.55$1.50-3.23%$1.56$1.507,611 shs$8.24 million04/22/2025$1.47$1.55+5.44%$1.59$1.479,537 shs$8.51 million04/21/2025$1.50$1.47-2.03%$1.50$1.4114,758 shs$8.07 million Get the Latest News and Ratings for APRE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aprea Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/18/2025$1.50$1.50$1.52$1.4811,487 shs$8.24 million04/17/2025$1.54$1.50-2.39%$1.52$1.4811,487 shs$8.24 million04/16/2025$1.58$1.54-2.72%$1.60$1.548,593 shs$8.44 million04/15/2025$1.58$1.58$1.66$1.5512,194 shs$8.68 million04/14/2025$1.55$1.58+1.94%$1.60$1.558,115 shs$8.68 million04/11/2025$1.56$1.55-0.70%$1.67$1.557,150 shs$8.51 million04/10/2025$1.59$1.56-1.51%$1.63$1.5216,359 shs$8.57 million04/09/2025$1.64$1.59-3.27%$1.66$1.5551,276 shs$8.71 million04/09/2025$1.64$1.59-3.27%$1.66$1.5551,276 shs$8.71 million04/08/2025$1.59$1.64+3.06%$1.80$1.5670,645 shs$9.00 million04/08/2025$1.59$1.64+3.06%$1.80$1.5670,645 shs$9.00 million04/07/2025$1.70$1.59-6.47%$1.70$1.5630,656 shs$8.73 million04/04/2025$1.80$1.70-5.56%$1.85$1.6789,919 shs$9.34 million04/03/2025$1.87$1.80-3.74%$1.89$1.7423,140 shs$9.89 million04/02/2025$1.92$1.87-2.60%$1.98$1.8528,590 shs$10.27 million04/01/2025$2.04$1.92-5.88%$2.10$1.9039,021 shs$10.55 million Related Companies OSTX Stock Chart NRXP Stock Chart SRZN Stock Chart ATHE Stock Chart CVKD Stock Chart PLUR Stock Chart MRNS Stock Chart KZR Stock Chart ALXO Stock Chart ESLA Stock Chart Receive APRE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aprea Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:APRE) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aprea Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aprea Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy APRE Stock Free APRE Stock Alerts